Background/Aims: Fine-tuning of renal calcium (Ca2+) reabsorption takes place in the late distal convoluted and connecting tubules (DCT2/CNT) of the kidney via transcellular Ca2+ transport. Here, Ca2+ enters the cell at the apical side via the epithelial Ca2+ channel transient receptor potential vanilloid 5 and is subsequently extruded at the basolateral side by the concerted actions of the plasma membrane Ca2+ ATPases and the Na+/Ca2+ exchanger 1 (NCX1). NCX1 is responsible for ∼70% of basolateral Ca2+ extrusion. The aim of this study was to determine the predominant NCX1 variant in the kidney and its role in Ca2+ transport. Methods: DCT2/CNT specific tubules were used to show the abundance of NCX1 specific isoforms. Renal NCX1 variants were cloned from mouse kidney tissue. Human Embryonic Kidney 293(T) cells were transiently transfected with NCX1.3, and Fura-2 measurements and 45Ca2+ uptake assays were performed to determine several characteristics of NCX1.3 in the reverse mode. Results: NCX1.3 was demonstrated to be the predominant NCX1 variant in the DCT2/CNT, next to NCX1.2 and NCX1.7. NCX1.3 could be inhibited by SN-6, an NCX-specific inhibitor, whereas stimulation of the cAMP/PKA or PKC-mediated pathway did not affect Ca2+ influx as measured in the reverse mode. Lowering intracellular Ca2+ concentrations resulted in a decreased Ca2+ uptake. Conclusion: NCX1.3 is the predominant NCX variant in the DCT2/CNT tubules. Its function is dependent on intracellular Ca2+ concentrations.

Keywords:
Sodium calcium exchange, NCX1, Kidney, Calcium transport
1.
Berridge MJ, Bootman MD, Roderick HL: Calcium signalling: dynamics, homeostasis and remodelling. Nat Rev Mol Cell Biol 2003;4:517-529.
2.
Hoenderop JG, Bindels RJ: Epithelial Ca2+ and Mg2+ channels in health and disease. J Am Soc Nephrol 2005;16:15-26.
3.
Hoenderop JG, van der Kemp AW, Hartog A, van de Graaf SF, van Os CH, Willems PH, Bindels RJ: Molecular identification of the apical Ca2+ channel in 1, 25-dihydroxyvitamin D3-responsive epithelia. J Biol Chem 1999;274:8375-8378.
4.
Lambers TT, Mahieu F, Oancea E, Hoofd L, de Lange F, Mensenkamp AR, Voets T, Nilius B, Clapham DE, Hoenderop JG, Bindels RJ: Calbindin-D28K dynamically controls TRPV5-mediated Ca2+ transport. EMBO J 2006;25:2978-2988.
5.
Hoenderop JG, Nilius B, Bindels RJ: Molecular mechanism of active Ca2+ reabsorption in the distal nephron. Annu Rev Physiol 2002;64:529-549.
6.
Lambers TT, Bindels RJ, Hoenderop JG: Coordinated control of renal Ca2+ handling. Kidney Int 2006;69:650-654.
7.
Hoenderop JG, Nilius B, Bindels RJ: Calcium absorption across epithelia. Physiol Rev 2005;85:373-422.
8.
Brini M, Carafoli E: The plasma membrane Ca2+ ATPase and the plasma membrane sodium calcium exchanger cooperate in the regulation of cell calcium. Cold Spring Harb Perspect Biol 2011;3:pii:a004168.
9.
Kip SN, Strehler EE: Characterization of PMCA isoforms and their contribution to transcellular Ca2+ flux in MDCK cells. Am J Physiol Renal Physiol 2003;284:F122-F132.
10.
Lytton J: Na+/Ca2+ exchangers: three mammalian gene families control Ca2+ transport. Biochem J 2007;406:365-382.
11.
Kofuji P, Lederer WJ, Schulze DH: Mutually exclusive and cassette exons underlie alternatively spliced isoforms of the Na/Ca exchanger. J Biol Chem 1994;269:5145-5149.
12.
Lee SL, Yu AS, Lytton J: Tissue-specific expression of Na(+)-Ca2+ exchanger isoforms. J Biol Chem 1994;269:14849-14852.
13.
Schulze DH, Polumuri SK, Gille T, Ruknudin A: Functional regulation of alternatively spliced Na+/Ca2+ exchanger (NCX1) isoforms. Ann N Y Acad Sci 2002;976:187-196.
14.
White KE, Gesek FA, Reilly RF, Friedman PA: NCX1 Na/Ca exchanger inhibition by antisense oligonucleotides in mouse distal convoluted tubule cells. Kidney Int 1998;54:897-906.
15.
Quednau BD, Nicoll DA, Philipson KD: Tissue specificity and alternative splicing of the Na+/Ca2+ exchanger isoforms NCX1, NCX2, and NCX3 in rat. Am J Physiol 1997;272:C1250-C1261.
16.
Khananshvili D: Sodium-calcium exchangers (NCX): molecular hallmarks underlying the tissue-specific and systemic functions. Pflugers Arch 2014;466:43-60.
17.
Shigekawa M, Iwamoto T: Cardiac Na(+)-Ca(2+) exchange: molecular and pharmacological aspects. Circ Res 2001;88:864-876.
18.
Nicoll DA, Longoni S, Philipson KD: Molecular cloning and functional expression of the cardiac sarcolemmal Na(+)-Ca2+ exchanger. Science 1990;250:562-565.
19.
van der Hagen EA, Lavrijsen M, van Zeeland F, Praetorius J, Bonny O, Bindels RJ, Hoenderop JG: Coordinated regulation of TRPV5-mediated Ca2+ transport in primary distal convolution cultures. Pflugers Arch 2014;466:2077-2087.
20.
de Groot T, Verkaart S, Xi Q, Bindels RJ, Hoenderop JG: The identification of histidine 712 as a critical residue for constitutive TRPV5 internalization. J Biol Chem 2010;285:28481-28487.
21.
Iwamoto T, Pan Y, Nakamura TY, Wakabayashi S, Shigekawa M: Protein kinase C-dependent regulation of Na+/Ca2+ exchanger isoforms NCX1 and NCX3 does not require their direct phosphorylation. Biochemistry 1998;37:17230-17238.
22.
Dyck C, Omelchenko A, Elias CL, Quednau BD, Philipson KD, Hnatowich M, Hryshko LV: Ionic regulatory properties of brain and kidney splice variants of the NCX1 Na(+)-Ca(2+) exchanger. J Gen Physiol 1999;114:701-711.
23.
Dimke H, Hoenderop JG, Bindels RJ: Hereditary tubular transport disorders: implications for renal handling of Ca2+ and Mg2+. Clin Sci (Lond) 2009;118:1-18.
24.
Markadieu N, Bindels RJ, Hoenderop JG: The renal connecting tubule: resolved and unresolved issues in Ca(2+) transport. Int J Biochem Cell Biol 2011;43:1-4.
25.
Kita S, Iwamoto T: Inhibitory mechanism of SN-6, a novel benzyloxyphenyl Na+/Ca2+ exchange inhibitor. Ann N Y Acad Sci 2007;1099:529-533.
26.
Iwamoto T, Inoue Y, Ito K, Sakaue T, Kita S, Katsuragi T: The exchanger inhibitory peptide region-dependent inhibition of Na+/Ca2+ exchange by SN-6 [2-[4-(4-nitrobenzyloxy)benzyl]thiazolidine-4-carboxylic acid ethyl ester], a novel benzyloxyphenyl derivative. Mol Pharmacol 2004;66:45-55.
27.
Nicoll DA, Sawaya MR, Kwon S, Cascio D, Philipson KD, Abramson J: The crystal structure of the primary Ca2+ sensor of the Na+/Ca2+ exchanger reveals a novel Ca2+ binding motif. J Biol Chem 2006;281:21577-21581.
28.
Hilge M: Ca2+ regulation of ion transport in the Na+/Ca2+ exchanger. J Biol Chem 2012;287:31641-31649.
29.
Dargan SL, Parker I: Buffer kinetics shape the spatiotemporal patterns of IP3-evoked Ca2+ signals. J Physiol 2003;553:775-788.
30.
Linck B, Qiu Z, He Z, Tong Q, Hilgemann DW, Philipson KD: Functional comparison of the three isoforms of the Na+/Ca2+ exchanger (NCX1, NCX2, NCX3). Am J Physiol 1998;274:C415-C423.
31.
van der Hagen EA, Lavrijsen M, van Zeeland F, Praetorius J, Bonny O, Bindels RJ, Hoenderop JG: Coordinated regulation of TRPV5-mediated ca2+ transport in primary distal convolution cultures. Pflugers Arch 2014;466:2077-2087.
32.
White KE, Gesek FA, Friedman PA: Structural and functional analysis of Na+/Ca2+ exchange in distal convoluted tubule cells. Am J Physiol 1996;271:F560-F570.
33.
Gotoh Y, Kita S, Fujii M, Tagashira H, Horie I, Arai Y, Uchida S, Iwamoto T: Genetic knockout and pharmacologic inhibition of NCX2 cause natriuresis and hypercalciuria. Biochem Biophys Res Commun 2015;456:670-675.
34.
Li JP, Kajiya H, Okamoto F, Nakao A, Iwamoto T, Okabe K: Three Na+/Ca2+ exchanger (NCX) variants are expressed in mouse osteoclasts and mediate calcium transport during bone resorption. Endocrinology 2007;148:2116-2125.
35.
Unlap MT, Bates E, Williams C, Komlosi P, Williams I, Kovacs G, Siroky B, Bell PD: Na+/Ca2+ exchanger: target for oxidative stress in salt-sensitive hypertension. Hypertension 2003;42:363-368.
36.
Unlap MT, Peti-Peterdi J, Bell PD: Cloning of mesangial cell Na(+)/Ca(2+) exchangers from Dahl/Rapp salt-sensitive/resistant rats. Am J Physiol Renal Physiol 2000;279:F177-F184.
37.
Hwang EF, Williams I, Kovacs G, Peti-Peterdi J, Siroky B, Rice WC, Bates E, Schwiebert EM, Unlap MT, Bell PD: Impaired ability of the Na+/Ca2+ exchanger from the Dahl/Rapp salt-sensitive rat to regulate cytosolic calcium. Am J Physiol Renal Physiol 2003;284:F1023-F1031.
38.
Dunn J, Elias CL, Le HD, Omelchenko A, Hryshko LV, Lytton J: The molecular determinants of ionic regulatory differences between brain and kidney Na+/Ca2+ exchanger (NCX1) isoforms. J Biol Chem 2002;277:33957-33962.
39.
Hilge M, Aelen J, Foarce A, Perrakis A, Vuister GW: Ca2+ regulation in the Na+/Ca2+ exchanger features a dual electrostatic switch mechanism. Proc Natl Acad Sci U S A 2009;106:14333-14338.
40.
Ruknudin AM, Wei SK, Haigney MC, Lederer WJ, Schulze DH: Phosphorylation and other conundrums of Na/Ca exchanger, NCX1. Ann N Y Acad Sci 2007;1099:103-118.
41.
Morad M, Cleemann L, Menick DR: NCX1 phosphorylation dilemma: a little closer to resolution. Focus on ‘full-length cardiac Na+/Ca2+ exchanger 1 protein is not phosphorylated by protein kinase A'. Am J Physiol Cell Physiol 2011;300:C970-C973.
42.
Sanders L, Rakovic S, Lowe M, Mattick PA, Terrar DA: Fundamental importance of Na+-Ca2+ exchange for the pacemaking mechanism in guinea-pig sino-atrial node. J Physiol 2006;571:639-649.
43.
Matsuoka S, Nicoll DA, Hryshko LV, Levitsky DO, Weiss JN, Philipson KD: Regulation of the cardiac Na(+)-Ca2+ exchanger by Ca2+. Mutational analysis of the Ca(2+)-binding domain. J Gen Physiol 1995;105:403-420.
44.
Li Z, Nicoll DA, Collins A, Hilgemann DW, Filoteo AG, Penniston JT, Weiss JN, Tomich JM, Philipson KD: Identification of a peptide inhibitor of the cardiac sarcolemmal Na(+)-Ca2+ exchanger. J Biol Chem 1991;266:1014-1020.
45.
Enyedi A, Penniston JT: Autoinhibitory domains of various Ca2+ transporters cross-react. J Biol Chem 1993;268:17120-17125.
46.
de Groot T, Kovalevskaya NV, Verkaart S, Schilderink N, Felici M, van der Hagen EA, Bindels RJ, Vuister GW, Hoenderop JG: Molecular mechanisms of calmodulin action on TRPV5 and modulation by parathyroid hormone. Mol Cell Biol 2011;31:2845-2853.
47.
Strehler EE, Caride AJ, Filoteo AG, Xiong Y, Penniston JT, Enyedi A: Plasma membrane Ca2+ ATPases as dynamic regulators of cellular calcium handling. Ann N Y Acad Sci 2007;1099:226-236.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.